MovDisordV3, PascalFrancis, Curation, bibRecord, 000900

Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue

Identifieur interne : 000900 ( PascalFrancis/Curation ); précédent : 000899; suivant : 000901

Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue

Auteurs : Valérie Cochen [France] ; Maria-Joao Ribeiro [France] ; Jean-Paul Nguyen [France] ; Jean-Marc Gurruchaga [France] ; Gabriel Villafane [France] ; Christian Loc'H [France] ; Gilles Defer [France] ; Yves Samson [France] ; Marc Peschanski [France] ; Philippe Hantraye [France] ; Pierre Cesaro [France] ; Philippe Remy [France]

Source :

Movement disorders [ 0885-3185 ] ; 2003.

RBID : Pascal:04-0010352

Descripteurs français

Pascal (Inist)
- Autogreffe, Mésencéphale, Cellule foetale, Tomographie émission positon, Ligand, Transport biologique, Dopamine, Parkinson maladie, Thérapie cellulaire, Traitement, Mécanisme action, Adulte.
Wicri :
- topic : Adulte.

English descriptors

KwdEn :
- Adult, Autograft, Biological transport, Cell therapy, Dopamine, Fetal cell, Ligand, Mechanism of action, Midbrain, Parkinson disease, Positron emission tomography, Treatment.

Abstract

We compared the striatal uptake of [¹⁸F]fluorodopa with [⁷⁶Br]-FE-CBT, a positron emission tomography (PET) ligand of the dopamine transporter (DAT), which estimates the density of dopamine nerve terminals, in 6 patients with Parkinson's disease grafted with fetal mesencephalic cells. There was no change in DAT ligand binding in the grafted putamen, despite a significant increase of [¹⁸F]fluorodopa uptake. This finding suggests that the clinical benefit induced by the graft is more related to increased dopaminergic activity than improved dopaminergic innervation in the host striatum and, therefore, that [¹⁸F]fluorodopa remains the optimal tracer to evaluate grafted PD patients. Further analysis showed that the clinical and [¹⁸F]fluorodopa uptake changes after the grafts were correlated with the number of ventral mesencephalae used for implantation.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 18`
A06				`@2 8`
A08	`01`	`1`	`ENG`	`@1 Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue`
A11	`01`	`1`		`@1 COCHEN (Valérie)`
A11	`02`	`1`		`@1 RIBEIRO (Maria-Joao)`
A11	`03`	`1`		`@1 NGUYEN (Jean-Paul)`
A11	`04`	`1`		`@1 GURRUCHAGA (Jean-Marc)`
A11	`05`	`1`		`@1 VILLAFANE (Gabriel)`
A11	`06`	`1`		`@1 LOC'H (Christian)`
A11	`07`	`1`		`@1 DEFER (Gilles)`
A11	`08`	`1`		`@1 SAMSON (Yves)`
A11	`09`	`1`		`@1 PESCHANSKI (Marc)`
A11	`10`	`1`		`@1 HANTRAYE (Philippe)`
A11	`11`	`1`		`@1 CESARO (Pierre)`
A11	`12`	`1`		`@1 REMY (Philippe)`
A14	`01`			`@1 Unité de Recherche Associée Commissariat à l'Energie Atomique (CEA)-Centre National de la Recherche Scientifique 2210 @2 Orsay @3 FRA @Z 1 aut. @Z 10 aut. @Z 12 aut.`
A14	`02`			`@1 CEA, Direction des Sciences du Vivant/Département de Recherche Médicale, Service Hospitalier Frédéric Joliot @2 Orsay @3 FRA @Z 2 aut. @Z 6 aut. @Z 8 aut. @Z 12 aut.`
A14	`03`			`@1 Département de Neurosciences, Centre Hospitalier Universitaire (CHU) Henri Mondor, AP-HP et Faculté de Médecine Paris-XII @2 Créteil @3 FRA @Z 3 aut. @Z 4 aut. @Z 5 aut. @Z 7 aut. @Z 9 aut. @Z 11 aut. @Z 12 aut.`
A14	`04`			`@1 Institut National de la Santé et de la Recherche Médicale U421, Faculté de Médecine @2 Créteil @3 FRA @Z 3 aut. @Z 9 aut. @Z 11 aut.`
A14	`05`			`@1 Service de Neurologie Déjerine @2 Caen @3 FRA @Z 7 aut.`
A14	`06`			`@1 Urgences Cérébro-Vasculaires, CHU Pitié-Salpêtrière @2 Paris @3 FRA @Z 8 aut.`
A20				`@1 928-932`
A21				`@1 2003`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000112695530120`
A44				`@0 0000 @1 © 2004 INIST-CNRS. All rights reserved.`
A45				`@0 20 ref.`
A47	`01`	`1`		`@0 04-0010352`
A60				`@1 P @3 CC`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 We compared the striatal uptake of [¹⁸F]fluorodopa with [⁷⁶Br]-FE-CBT, a positron emission tomography (PET) ligand of the dopamine transporter (DAT), which estimates the density of dopamine nerve terminals, in 6 patients with Parkinson's disease grafted with fetal mesencephalic cells. There was no change in DAT ligand binding in the grafted putamen, despite a significant increase of [¹⁸F]fluorodopa uptake. This finding suggests that the clinical benefit induced by the graft is more related to increased dopaminergic activity than improved dopaminergic innervation in the host striatum and, therefore, that [¹⁸F]fluorodopa remains the optimal tracer to evaluate grafted PD patients. Further analysis showed that the clinical and [¹⁸F]fluorodopa uptake changes after the grafts were correlated with the number of ventral mesencephalae used for implantation.
C02	`01`	`X`		`@0 002B27D03`
C03	`01`	`X`	`FRE`	`@0 Autogreffe @5 01`
C03	`01`	`X`	`ENG`	`@0 Autograft @5 01`
C03	`01`	`X`	`SPA`	`@0 Autoinjerto @5 01`
C03	`02`	`X`	`FRE`	`@0 Mésencéphale @5 02`
C03	`02`	`X`	`ENG`	`@0 Midbrain @5 02`
C03	`02`	`X`	`SPA`	`@0 Mesencéfalo @5 02`
C03	`03`	`X`	`FRE`	`@0 Cellule foetale @5 03`
C03	`03`	`X`	`ENG`	`@0 Fetal cell @5 03`
C03	`03`	`X`	`SPA`	`@0 Célula fetal @5 03`
C03	`04`	`X`	`FRE`	`@0 Tomographie émission positon @5 04`
C03	`04`	`X`	`ENG`	`@0 Positron emission tomography @5 04`
C03	`04`	`X`	`SPA`	`@0 Tomografía emisión positrones @5 04`
C03	`05`	`X`	`FRE`	`@0 Ligand @5 07`
C03	`05`	`X`	`ENG`	`@0 Ligand @5 07`
C03	`05`	`X`	`SPA`	`@0 Ligando @5 07`
C03	`06`	`X`	`FRE`	`@0 Transport biologique @5 08`
C03	`06`	`X`	`ENG`	`@0 Biological transport @5 08`
C03	`06`	`X`	`SPA`	`@0 Transporte biológico @5 08`
C03	`07`	`X`	`FRE`	`@0 Dopamine @2 NK @2 FR @5 09`
C03	`07`	`X`	`ENG`	`@0 Dopamine @2 NK @2 FR @5 09`
C03	`07`	`X`	`SPA`	`@0 Dopamina @2 NK @2 FR @5 09`
C03	`08`	`X`	`FRE`	`@0 Parkinson maladie @5 10`
C03	`08`	`X`	`ENG`	`@0 Parkinson disease @5 10`
C03	`08`	`X`	`SPA`	`@0 Parkinson enfermedad @5 10`
C03	`09`	`X`	`FRE`	`@0 Thérapie cellulaire @5 17`
C03	`09`	`X`	`ENG`	`@0 Cell therapy @5 17`
C03	`09`	`X`	`SPA`	`@0 Terapia celular @5 17`
C03	`10`	`X`	`FRE`	`@0 Traitement @5 18`
C03	`10`	`X`	`ENG`	`@0 Treatment @5 18`
C03	`10`	`X`	`SPA`	`@0 Tratamiento @5 18`
C03	`11`	`X`	`FRE`	`@0 Mécanisme action @5 19`
C03	`11`	`X`	`ENG`	`@0 Mechanism of action @5 19`
C03	`11`	`X`	`SPA`	`@0 Mecanismo acción @5 19`
C03	`12`	`X`	`FRE`	`@0 Adulte @5 20`
C03	`12`	`X`	`ENG`	`@0 Adult @5 20`
C03	`12`	`X`	`SPA`	`@0 Adulto @5 20`
C07	`01`	`X`	`FRE`	`@0 Homme`
C07	`01`	`X`	`ENG`	`@0 Human`
C07	`01`	`X`	`SPA`	`@0 Hombre`
C07	`02`	`X`	`FRE`	`@0 Greffe @5 37`
C07	`02`	`X`	`ENG`	`@0 Graft @5 37`
C07	`02`	`X`	`SPA`	`@0 Injerto @5 37`
C07	`03`	`X`	`FRE`	`@0 Exploration radioisotopique @5 45`
C07	`03`	`X`	`ENG`	`@0 Radionuclide study @5 45`
C07	`03`	`X`	`SPA`	`@0 Exploración radioisotópica @5 45`
C07	`04`	`X`	`FRE`	`@0 Système nerveux pathologie @5 61`
C07	`04`	`X`	`ENG`	`@0 Nervous system diseases @5 61`
C07	`04`	`X`	`SPA`	`@0 Sistema nervioso patología @5 61`
C07	`05`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 62`
C07	`05`	`X`	`ENG`	`@0 Central nervous system disease @5 62`
C07	`05`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 62`
C07	`06`	`X`	`FRE`	`@0 Encéphale pathologie @5 63`
C07	`06`	`X`	`ENG`	`@0 Cerebral disorder @5 63`
C07	`06`	`X`	`SPA`	`@0 Encéfalo patología @5 63`
C07	`07`	`X`	`FRE`	`@0 Extrapyramidal syndrome @5 64`
C07	`07`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 64`
C07	`07`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 64`
C07	`08`	`X`	`FRE`	`@0 Maladie dégénérative @5 65`
C07	`08`	`X`	`ENG`	`@0 Degenerative disease @5 65`
C07	`08`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 65`
N21				`@1 006`
N82				`@1 PSI`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002421

Links to Exploration step

Pascal:04-0010352

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue</title>
<author><name sortKey="Cochen, Valerie" sort="Cochen, Valerie" uniqKey="Cochen V" first="Valérie" last="Cochen">Valérie Cochen</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Unité de Recherche Associée Commissariat à l'Energie Atomique (CEA)-Centre National de la Recherche Scientifique 2210</s1>
<s2>Orsay</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Ribeiro, Maria Joao" sort="Ribeiro, Maria Joao" uniqKey="Ribeiro M" first="Maria-Joao" last="Ribeiro">Maria-Joao Ribeiro</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>CEA, Direction des Sciences du Vivant/Département de Recherche Médicale, Service Hospitalier Frédéric Joliot</s1>
<s2>Orsay</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Nguyen, Jean Paul" sort="Nguyen, Jean Paul" uniqKey="Nguyen J" first="Jean-Paul" last="Nguyen">Jean-Paul Nguyen</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Département de Neurosciences, Centre Hospitalier Universitaire (CHU) Henri Mondor, AP-HP et Faculté de Médecine Paris-XII</s1>
<s2>Créteil</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Institut National de la Santé et de la Recherche Médicale U421, Faculté de Médecine</s1>
<s2>Créteil</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Gurruchaga, Jean Marc" sort="Gurruchaga, Jean Marc" uniqKey="Gurruchaga J" first="Jean-Marc" last="Gurruchaga">Jean-Marc Gurruchaga</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Département de Neurosciences, Centre Hospitalier Universitaire (CHU) Henri Mondor, AP-HP et Faculté de Médecine Paris-XII</s1>
<s2>Créteil</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Villafane, Gabriel" sort="Villafane, Gabriel" uniqKey="Villafane G" first="Gabriel" last="Villafane">Gabriel Villafane</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Département de Neurosciences, Centre Hospitalier Universitaire (CHU) Henri Mondor, AP-HP et Faculté de Médecine Paris-XII</s1>
<s2>Créteil</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Loc H, Christian" sort="Loc H, Christian" uniqKey="Loc H C" first="Christian" last="Loc'H">Christian Loc'H</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>CEA, Direction des Sciences du Vivant/Département de Recherche Médicale, Service Hospitalier Frédéric Joliot</s1>
<s2>Orsay</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Defer, Gilles" sort="Defer, Gilles" uniqKey="Defer G" first="Gilles" last="Defer">Gilles Defer</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Département de Neurosciences, Centre Hospitalier Universitaire (CHU) Henri Mondor, AP-HP et Faculté de Médecine Paris-XII</s1>
<s2>Créteil</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Service de Neurologie Déjerine</s1>
<s2>Caen</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Samson, Yves" sort="Samson, Yves" uniqKey="Samson Y" first="Yves" last="Samson">Yves Samson</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>CEA, Direction des Sciences du Vivant/Département de Recherche Médicale, Service Hospitalier Frédéric Joliot</s1>
<s2>Orsay</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Urgences Cérébro-Vasculaires, CHU Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Peschanski, Marc" sort="Peschanski, Marc" uniqKey="Peschanski M" first="Marc" last="Peschanski">Marc Peschanski</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Département de Neurosciences, Centre Hospitalier Universitaire (CHU) Henri Mondor, AP-HP et Faculté de Médecine Paris-XII</s1>
<s2>Créteil</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Institut National de la Santé et de la Recherche Médicale U421, Faculté de Médecine</s1>
<s2>Créteil</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Hantraye, Philippe" sort="Hantraye, Philippe" uniqKey="Hantraye P" first="Philippe" last="Hantraye">Philippe Hantraye</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Unité de Recherche Associée Commissariat à l'Energie Atomique (CEA)-Centre National de la Recherche Scientifique 2210</s1>
<s2>Orsay</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Cesaro, Pierre" sort="Cesaro, Pierre" uniqKey="Cesaro P" first="Pierre" last="Cesaro">Pierre Cesaro</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Département de Neurosciences, Centre Hospitalier Universitaire (CHU) Henri Mondor, AP-HP et Faculté de Médecine Paris-XII</s1>
<s2>Créteil</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Institut National de la Santé et de la Recherche Médicale U421, Faculté de Médecine</s1>
<s2>Créteil</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Remy, Philippe" sort="Remy, Philippe" uniqKey="Remy P" first="Philippe" last="Remy">Philippe Remy</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Unité de Recherche Associée Commissariat à l'Energie Atomique (CEA)-Centre National de la Recherche Scientifique 2210</s1>
<s2>Orsay</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>CEA, Direction des Sciences du Vivant/Département de Recherche Médicale, Service Hospitalier Frédéric Joliot</s1>
<s2>Orsay</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Département de Neurosciences, Centre Hospitalier Universitaire (CHU) Henri Mondor, AP-HP et Faculté de Médecine Paris-XII</s1>
<s2>Créteil</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">04-0010352</idno>
<date when="2003">2003</date>
<idno type="stanalyst">PASCAL 04-0010352 INIST</idno>
<idno type="RBID">Pascal:04-0010352</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002421</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000900</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue</title>
<author><name sortKey="Cochen, Valerie" sort="Cochen, Valerie" uniqKey="Cochen V" first="Valérie" last="Cochen">Valérie Cochen</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Unité de Recherche Associée Commissariat à l'Energie Atomique (CEA)-Centre National de la Recherche Scientifique 2210</s1>
<s2>Orsay</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Ribeiro, Maria Joao" sort="Ribeiro, Maria Joao" uniqKey="Ribeiro M" first="Maria-Joao" last="Ribeiro">Maria-Joao Ribeiro</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>CEA, Direction des Sciences du Vivant/Département de Recherche Médicale, Service Hospitalier Frédéric Joliot</s1>
<s2>Orsay</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Nguyen, Jean Paul" sort="Nguyen, Jean Paul" uniqKey="Nguyen J" first="Jean-Paul" last="Nguyen">Jean-Paul Nguyen</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Département de Neurosciences, Centre Hospitalier Universitaire (CHU) Henri Mondor, AP-HP et Faculté de Médecine Paris-XII</s1>
<s2>Créteil</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Institut National de la Santé et de la Recherche Médicale U421, Faculté de Médecine</s1>
<s2>Créteil</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Gurruchaga, Jean Marc" sort="Gurruchaga, Jean Marc" uniqKey="Gurruchaga J" first="Jean-Marc" last="Gurruchaga">Jean-Marc Gurruchaga</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Département de Neurosciences, Centre Hospitalier Universitaire (CHU) Henri Mondor, AP-HP et Faculté de Médecine Paris-XII</s1>
<s2>Créteil</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Villafane, Gabriel" sort="Villafane, Gabriel" uniqKey="Villafane G" first="Gabriel" last="Villafane">Gabriel Villafane</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Département de Neurosciences, Centre Hospitalier Universitaire (CHU) Henri Mondor, AP-HP et Faculté de Médecine Paris-XII</s1>
<s2>Créteil</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Loc H, Christian" sort="Loc H, Christian" uniqKey="Loc H C" first="Christian" last="Loc'H">Christian Loc'H</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>CEA, Direction des Sciences du Vivant/Département de Recherche Médicale, Service Hospitalier Frédéric Joliot</s1>
<s2>Orsay</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Defer, Gilles" sort="Defer, Gilles" uniqKey="Defer G" first="Gilles" last="Defer">Gilles Defer</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Département de Neurosciences, Centre Hospitalier Universitaire (CHU) Henri Mondor, AP-HP et Faculté de Médecine Paris-XII</s1>
<s2>Créteil</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Service de Neurologie Déjerine</s1>
<s2>Caen</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Samson, Yves" sort="Samson, Yves" uniqKey="Samson Y" first="Yves" last="Samson">Yves Samson</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>CEA, Direction des Sciences du Vivant/Département de Recherche Médicale, Service Hospitalier Frédéric Joliot</s1>
<s2>Orsay</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Urgences Cérébro-Vasculaires, CHU Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Peschanski, Marc" sort="Peschanski, Marc" uniqKey="Peschanski M" first="Marc" last="Peschanski">Marc Peschanski</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Département de Neurosciences, Centre Hospitalier Universitaire (CHU) Henri Mondor, AP-HP et Faculté de Médecine Paris-XII</s1>
<s2>Créteil</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Institut National de la Santé et de la Recherche Médicale U421, Faculté de Médecine</s1>
<s2>Créteil</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Hantraye, Philippe" sort="Hantraye, Philippe" uniqKey="Hantraye P" first="Philippe" last="Hantraye">Philippe Hantraye</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Unité de Recherche Associée Commissariat à l'Energie Atomique (CEA)-Centre National de la Recherche Scientifique 2210</s1>
<s2>Orsay</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Cesaro, Pierre" sort="Cesaro, Pierre" uniqKey="Cesaro P" first="Pierre" last="Cesaro">Pierre Cesaro</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Département de Neurosciences, Centre Hospitalier Universitaire (CHU) Henri Mondor, AP-HP et Faculté de Médecine Paris-XII</s1>
<s2>Créteil</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Institut National de la Santé et de la Recherche Médicale U421, Faculté de Médecine</s1>
<s2>Créteil</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Remy, Philippe" sort="Remy, Philippe" uniqKey="Remy P" first="Philippe" last="Remy">Philippe Remy</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Unité de Recherche Associée Commissariat à l'Energie Atomique (CEA)-Centre National de la Recherche Scientifique 2210</s1>
<s2>Orsay</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>CEA, Direction des Sciences du Vivant/Département de Recherche Médicale, Service Hospitalier Frédéric Joliot</s1>
<s2>Orsay</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Département de Neurosciences, Centre Hospitalier Universitaire (CHU) Henri Mondor, AP-HP et Faculté de Médecine Paris-XII</s1>
<s2>Créteil</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2003">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Autograft</term>
<term>Biological transport</term>
<term>Cell therapy</term>
<term>Dopamine</term>
<term>Fetal cell</term>
<term>Ligand</term>
<term>Mechanism of action</term>
<term>Midbrain</term>
<term>Parkinson disease</term>
<term>Positron emission tomography</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Autogreffe</term>
<term>Mésencéphale</term>
<term>Cellule foetale</term>
<term>Tomographie émission positon</term>
<term>Ligand</term>
<term>Transport biologique</term>
<term>Dopamine</term>
<term>Parkinson maladie</term>
<term>Thérapie cellulaire</term>
<term>Traitement</term>
<term>Mécanisme action</term>
<term>Adulte</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Adulte</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We compared the striatal uptake of [<sup>18</sup>
F]fluorodopa with [<sup>76</sup>
Br]-FE-CBT, a positron emission tomography (PET) ligand of the dopamine transporter (DAT), which estimates the density of dopamine nerve terminals, in 6 patients with Parkinson's disease grafted with fetal mesencephalic cells. There was no change in DAT ligand binding in the grafted putamen, despite a significant increase of [<sup>18</sup>
F]fluorodopa uptake. This finding suggests that the clinical benefit induced by the graft is more related to increased dopaminergic activity than improved dopaminergic innervation in the host striatum and, therefore, that [<sup>18</sup>
F]fluorodopa remains the optimal tracer to evaluate grafted PD patients. Further analysis showed that the clinical and [<sup>18</sup>
F]fluorodopa uptake changes after the grafts were correlated with the number of ventral mesencephalae used for implantation.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>18</s2>
</fA05>
<fA06><s2>8</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>COCHEN (Valérie)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>RIBEIRO (Maria-Joao)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>NGUYEN (Jean-Paul)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>GURRUCHAGA (Jean-Marc)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>VILLAFANE (Gabriel)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>LOC'H (Christian)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>DEFER (Gilles)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>SAMSON (Yves)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>PESCHANSKI (Marc)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>HANTRAYE (Philippe)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>CESARO (Pierre)</s1>
</fA11>
<fA11 i1="12" i2="1"><s1>REMY (Philippe)</s1>
</fA11>
<fA14 i1="01"><s1>Unité de Recherche Associée Commissariat à l'Energie Atomique (CEA)-Centre National de la Recherche Scientifique 2210</s1>
<s2>Orsay</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>12 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>CEA, Direction des Sciences du Vivant/Département de Recherche Médicale, Service Hospitalier Frédéric Joliot</s1>
<s2>Orsay</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>12 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Département de Neurosciences, Centre Hospitalier Universitaire (CHU) Henri Mondor, AP-HP et Faculté de Médecine Paris-XII</s1>
<s2>Créteil</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Institut National de la Santé et de la Recherche Médicale U421, Faculté de Médecine</s1>
<s2>Créteil</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Service de Neurologie Déjerine</s1>
<s2>Caen</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Urgences Cérébro-Vasculaires, CHU Pitié-Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA20><s1>928-932</s1>
</fA20>
<fA21><s1>2003</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000112695530120</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2004 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>20 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>04-0010352</s0>
</fA47>
<fA60><s1>P</s1>
<s3>CC</s3>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>We compared the striatal uptake of [<sup>18</sup>
F]fluorodopa with [<sup>76</sup>
Br]-FE-CBT, a positron emission tomography (PET) ligand of the dopamine transporter (DAT), which estimates the density of dopamine nerve terminals, in 6 patients with Parkinson's disease grafted with fetal mesencephalic cells. There was no change in DAT ligand binding in the grafted putamen, despite a significant increase of [<sup>18</sup>
F]fluorodopa uptake. This finding suggests that the clinical benefit induced by the graft is more related to increased dopaminergic activity than improved dopaminergic innervation in the host striatum and, therefore, that [<sup>18</sup>
F]fluorodopa remains the optimal tracer to evaluate grafted PD patients. Further analysis showed that the clinical and [<sup>18</sup>
F]fluorodopa uptake changes after the grafts were correlated with the number of ventral mesencephalae used for implantation.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B27D03</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Autogreffe</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Autograft</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Autoinjerto</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Mésencéphale</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Midbrain</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Mesencéfalo</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Cellule foetale</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Fetal cell</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Célula fetal</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Tomographie émission positon</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Positron emission tomography</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Tomografía emisión positrones</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Ligand</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Ligand</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Ligando</s0>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Transport biologique</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Biological transport</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Transporte biológico</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Dopamine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Dopamine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Dopamina</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>09</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>10</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>10</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>10</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Thérapie cellulaire</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Cell therapy</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Terapia celular</s0>
<s5>17</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Traitement</s0>
<s5>18</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Treatment</s0>
<s5>18</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>18</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Mécanisme action</s0>
<s5>19</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Mechanism of action</s0>
<s5>19</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Mecanismo acción</s0>
<s5>19</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Adulte</s0>
<s5>20</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Adult</s0>
<s5>20</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Adulto</s0>
<s5>20</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Homme</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Human</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Hombre</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Greffe</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Graft</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Injerto</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Exploration radioisotopique</s0>
<s5>45</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Radionuclide study</s0>
<s5>45</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Exploración radioisotópica</s0>
<s5>45</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>61</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>61</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>61</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>62</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>62</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>62</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>63</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>63</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>63</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>64</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>64</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>64</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>65</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>65</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>65</s5>
</fC07>
<fN21><s1>006</s1>
</fN21>
<fN82><s1>PSI</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000900 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000900 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:04-0010352
   |texte=   Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue

Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri